BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 34602387)

  • 1. Azithromycin inhibits the production of MUC5AC in the airway mucosa of patients with bronchiectasis induced by Pseudomonas aeruginosa.
    Wang J; Xu L; Lv Y; Sun L
    Pak J Pharm Sci; 2021 May; 34(3(Special)):1179-1185. PubMed ID: 34602387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of long-term azithromycin therapy on airway oxidative stress markers in non-cystic fibrosis bronchiectasis.
    Diego AD; Milara J; Martinez-Moragón E; Palop M; León M; Cortijo J
    Respirology; 2013 Oct; 18(7):1056-62. PubMed ID: 23714268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Azithromycin inhibits MUC5AC production induced by the Pseudomonas aeruginosa autoinducer N-(3-Oxododecanoyl) homoserine lactone in NCI-H292 Cells.
    Imamura Y; Yanagihara K; Mizuta Y; Seki M; Ohno H; Higashiyama Y; Miyazaki Y; Tsukamoto K; Hirakata Y; Tomono K; Kadota J; Kohno S
    Antimicrob Agents Chemother; 2004 Sep; 48(9):3457-61. PubMed ID: 15328111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Long-term treatment with azithromycin in a patient with idiopathic bronchiectasis].
    Máiz Carro L
    Arch Bronconeumol; 2005 May; 41(5):295. PubMed ID: 15919012
    [No Abstract]   [Full Text] [Related]  

  • 5. Lung function in bronchiectasis: the influence of Pseudomonas aeruginosa.
    Evans SA; Turner SM; Bosch BJ; Hardy CC; Woodhead MA
    Eur Respir J; 1996 Aug; 9(8):1601-4. PubMed ID: 8866579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrolides protect against
    Fan LC; Lin JL; Yang JW; Mao B; Lu HW; Ge BX; Choi AMK; Xu JF
    Am J Physiol Lung Cell Mol Physiol; 2017 Oct; 313(4):L677-L686. PubMed ID: 28684545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelin-1 in stable bronchiectasis.
    Zheng L; Tipoe G; Lam WK; Ho JC; Shum I; Ooi GC; Leung R; Tsang KW
    Eur Respir J; 2000 Jul; 16(1):146-9. PubMed ID: 10933101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A crucial role of Flagellin in the induction of airway mucus production by Pseudomonas aeruginosa.
    Ben Mohamed F; Garcia-Verdugo I; Medina M; Balloy V; Chignard M; Ramphal R; Touqui L
    PLoS One; 2012; 7(7):e39888. PubMed ID: 22768318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutrophil extracellular traps, disease severity, and antibiotic response in bronchiectasis: an international, observational, multicohort study.
    Keir HR; Shoemark A; Dicker AJ; Perea L; Pollock J; Giam YH; Suarez-Cuartin G; Crichton ML; Lonergan M; Oriano M; Cant E; Einarsson GG; Furrie E; Elborn JS; Fong CJ; Finch S; Rogers GB; Blasi F; Sibila O; Aliberti S; Simpson JL; Huang JTJ; Chalmers JD
    Lancet Respir Med; 2021 Aug; 9(8):873-884. PubMed ID: 33609487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Inhaled colistin in elderly patients with non-cystic fibrosis bronchiectasis and chronic Pseudomonas aeruginosa bronchial infection].
    Tabernero Huguet E; Gil Alaña P; Alkiza Basañez R; Hernández Gil A; Garros Garay J; Artola Igarza JL
    Rev Esp Geriatr Gerontol; 2015; 50(3):111-5. PubMed ID: 25724860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiotic therapy for stable non-CF bronchiectasis in adults - A systematic review.
    Fjaellegaard K; Sin MD; Browatzki A; Ulrik CS
    Chron Respir Dis; 2017 May; 14(2):174-186. PubMed ID: 27507832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non cystic fibrosis bronchiectasis: A longitudinal retrospective observational cohort study of Pseudomonas persistence and resistance.
    McDonnell MJ; Jary HR; Perry A; MacFarlane JG; Hester KL; Small T; Molyneux C; Perry JD; Walton KE; De Soyza A
    Respir Med; 2015 Jun; 109(6):716-26. PubMed ID: 25200914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Azithromycin treatment alters gene expression in inflammatory, lipid metabolism, and cell cycle pathways in well-differentiated human airway epithelia.
    Ribeiro CM; Hurd H; Wu Y; Martino ME; Jones L; Brighton B; Boucher RC; O'Neal WK
    PLoS One; 2009 Jun; 4(6):e5806. PubMed ID: 19503797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eradication of
    Blanco-Aparicio M; Saleta Canosa JL; Valiño López P; Martín Egaña MT; Vidal García I; Montero Martínez C
    Chron Respir Dis; 2019; 16():1479973119872513. PubMed ID: 31480862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Addition of inhaled tobramycin to ciprofloxacin for acute exacerbations of Pseudomonas aeruginosa infection in adult bronchiectasis.
    Bilton D; Henig N; Morrissey B; Gotfried M
    Chest; 2006 Nov; 130(5):1503-10. PubMed ID: 17099030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of a novel nonantibiotic macrolide, EM900, on cytokine and mucin gene expression in a human airway epithelial cell line.
    Otsu K; Ishinaga H; Suzuki S; Sugawara A; Sunazuka T; Omura S; Jono H; Takeuchi K
    Pharmacology; 2011; 88(5-6):327-32. PubMed ID: 22116077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrolide Treatment Inhibits Pseudomonas aeruginosa Quorum Sensing in Non-Cystic Fibrosis Bronchiectasis. An Analysis from the Bronchiectasis and Low-Dose Erythromycin Study Trial.
    Burr LD; Rogers GB; Chen AC; Hamilton BR; Pool GF; Taylor SL; Venter D; Bowler SD; Biga S; McGuckin MA
    Ann Am Thorac Soc; 2016 Oct; 13(10):1697-1703. PubMed ID: 27464029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different effects of telithromycin on MUC5AC production induced by human neutrophil peptide-1 or lipopolysaccharide in NCI-H292 cells compared with azithromycin and clarithromycin.
    Ishimoto H; Mukae H; Sakamoto N; Amenomori M; Kitazaki T; Imamura Y; Fujita H; Ishii H; Nakayama S; Yanagihara K; Kohno S
    J Antimicrob Chemother; 2009 Jan; 63(1):109-14. PubMed ID: 18931390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Randomized Controlled Trial of Atorvastatin in Patients With Bronchiectasis Infected With Pseudomonas Aeruginosa: A Proof of Concept Study.
    Bedi P; Chalmers JD; Graham C; Clarke A; Donaldson S; Doherty C; Govan JRW; Davidson DJ; Rossi AG; Hill AT
    Chest; 2017 Aug; 152(2):368-378. PubMed ID: 28554732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Airway "Resistotypes" and Clinical Outcomes in Bronchiectasis.
    Mac Aogáin M; Xaverius Ivan F; Jaggi TK; Richardson H; Shoemark A; Narayana JK; Dicker AJ; Koh MS; Lee KCH; Thun How O; Poh ME; Chin KK; Hou ALY; Ser Hon P; Low TB; Abisheganaden JA; Dimakou K; Digalaki A; Kosti C; Gkousiou A; Hansbro PM; Blasi F; Aliberti S; Chalmers JD; Chotirmall SH
    Am J Respir Crit Care Med; 2024 Jul; 210(1):47-62. PubMed ID: 38271608
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.